These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 18852532

  • 1. 1α,24(S)(OH)2D2 normalizes bone morphology and serum parathyroid hormone without hypercalcemia in 25-hydroxyvitamin D-1-hydroxylase (CYP27B1)-deficient mice, an animal model of vitamin D deficiency with secondary hyperparathyroidism.
    St-Arnaud R, Arabian A, Yu VW, Akhouayri O, Knutson JC, Strugnell SA.
    J Endocrinol Invest; 2008 Aug; 31(8):711-7. PubMed ID: 18852532
    [Abstract] [Full Text] [Related]

  • 2. Rescue of the pseudo-vitamin D deficiency rickets phenotype of CYP27B1-deficient mice by treatment with 1,25-dihydroxyvitamin D3: biochemical, histomorphometric, and biomechanical analyses.
    Dardenne O, Prudhomme J, Hacking SA, Glorieux FH, St-Arnaud R.
    J Bone Miner Res; 2003 Apr; 18(4):637-43. PubMed ID: 12674324
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone.
    Finch JL, Brown AJ, Slatopolsky E.
    J Am Soc Nephrol; 1999 May; 10(5):980-5. PubMed ID: 10232683
    [Abstract] [Full Text] [Related]

  • 7. Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1).
    Dardenne O, Prud'homme J, Hacking SA, Glorieux FH, St-Arnaud R.
    Bone; 2003 Apr; 32(4):332-40. PubMed ID: 12689675
    [Abstract] [Full Text] [Related]

  • 8. The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells.
    Brown AJ, Ritter CS, Knutson JC, Strugnell SA.
    Nephrol Dial Transplant; 2006 Mar; 21(3):644-50. PubMed ID: 16221703
    [Abstract] [Full Text] [Related]

  • 9. 1alpha-hydroxyvitamin D2 partially dissociates between preservation of cancellous bone mass and effects on calcium homeostasis in ovariectomized rats.
    Erben RG, Bante U, Birner H, Stangassinger M.
    Calcif Tissue Int; 1997 May; 60(5):449-56. PubMed ID: 9115163
    [Abstract] [Full Text] [Related]

  • 10. Calcitonin is a major regulator for the expression of renal 25-hydroxyvitamin D3-1alpha-hydroxylase gene in normocalcemic rats.
    Shinki T, Ueno Y, DeLuca HF, Suda T.
    Proc Natl Acad Sci U S A; 1999 Jul 06; 96(14):8253-8. PubMed ID: 10393981
    [Abstract] [Full Text] [Related]

  • 11. A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia.
    Slatopolsky E, Finch J, Ritter C, Denda M, Morrissey J, Brown A, DeLuca H.
    Am J Kidney Dis; 1995 Nov 06; 26(5):852-60. PubMed ID: 7485144
    [Abstract] [Full Text] [Related]

  • 12. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF.
    Clin Cancer Res; 2000 Mar 06; 6(3):901-8. PubMed ID: 10741714
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Mar 06; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 16. Comparison of active vitamin D compounds and a calcimimetic in mineral homeostasis.
    Nguyen-Yamamoto L, Bolivar I, Strugnell SA, Goltzman D.
    J Am Soc Nephrol; 2010 Oct 06; 21(10):1713-23. PubMed ID: 20651168
    [Abstract] [Full Text] [Related]

  • 17. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
    Chow EC, Quach HP, Vieth R, Pang KS.
    Am J Physiol Endocrinol Metab; 2013 May 01; 304(9):E977-89. PubMed ID: 23482451
    [Abstract] [Full Text] [Related]

  • 18. Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets.
    Dardenne O, Prud'homme J, Arabian A, Glorieux FH, St-Arnaud R.
    Endocrinology; 2001 Jul 01; 142(7):3135-41. PubMed ID: 11416036
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.